Dräger Becomes Strategic Investor in Hypros (fmr. GWA Hygiene)

Written By

Tobias Gebhardt

Tobias Gebhardt

Published On

Jan 31, 2022

Category

  • Company
  • Investments
Dräger Becomes Strategic Investor in Hypros (fmr. GWA Hygiene)

Lübeck/Stralsund, January 31, 2022 – The internationally leading manufacturer of medical and safety technology Dräger and digital health startup Hypros (fmr. GWA Hygiene) announce a groundbreaking investment partnership.

Strategic Significance

The investment marks an important milestone:

  • Dräger as a renowned medical technology manufacturer
  • Complement to existing investors like MIG Fonds
  • Strengthening of market position
  • Acceleration of internationalization

Addressed Challenges

Hypros solves critical problems in healthcare:

Current Situation

  • Inefficient processes
  • Increasing nursing shortage
  • Rising hygiene risks
  • Threat to patient safety

NosoEx® Solution

  • Digital hygiene assistant
  • Sensor system for behavior tracking
  • Detailed analyses
  • Real-time monitoring

Partnership Statements

Tobias Gebhardt, CEO of Hypros

“There’s no time for hygiene measures – this is something we often hear when talking to hospital staff. Therefore, the goal must be to relieve clinic staff so they have more time for patient care, including attention to hygiene. We quickly realized that Dräger and we share this ambition.”

Jens Altmann, Head of Business Unit “Data Business” at Dräger

“With the investment in Hypros, we will work together with GWA to further expand our real-time locating system Dräger Discover to support hygiene routines. This strengthens our joint offering to improve workflows in acute care.”

Concrete Collaboration

The partnership is already evident in concrete projects:

Neonatology Pilot Project

  • Identification of transmission risks
  • Focus on acute care areas
  • Integration of digital solutions
  • Preventive measures

Technology Integration

  • Connection with Dräger Discover
  • Extension of real-time tracking
  • Optimization of hygiene routines
  • Improvement of workflows

Investment Goals

The new capital will be specifically used for:

  1. Product Development

    • Further development of digital solutions
    • Integration of new features
    • Technology optimization
  2. Market Expansion

    • Strengthening of sales
    • International expansion
    • European roll-out
  3. Pilot Projects

    • Ongoing projects in several EU countries
    • Intensification of partnerships
    • Validation of new use cases

Future Perspective

The partnership between Dräger and Hypros promises:

  • Accelerated digitalization in healthcare
  • Improved patient safety
  • Optimized workflows
  • International presence